| |
| |
|
| Insider
Information: |
Novak Rodger |
| Relationship: |
President, Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
573,007 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$30,793,396 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
573,007 |
|
|
| Total
Value |
$30,793,396 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
President, Director |
2021-06-30 |
573,007 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
67 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-06-23 |
4 |
AS |
$75.00 |
$3,750,000 |
D/D |
(50,000) |
698,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-07-01 |
4 |
AS |
$80.00 |
$4,000,000 |
D/D |
(50,000) |
648,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-07-07 |
4 |
OE |
$1.81 |
$281,907 |
D/D |
25,000 |
673,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-07-07 |
4 |
AS |
$90.00 |
$2,250,000 |
D/D |
(25,000) |
648,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-08-19 |
4 |
OE |
$14.00 |
$350,000 |
D/D |
25,000 |
673,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-08-19 |
4 |
AS |
$100.00 |
$2,500,000 |
D/D |
(25,000) |
648,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-09-01 |
4 |
OE |
$14.00 |
$359,059 |
D/D |
25,000 |
673,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-09-01 |
4 |
AS |
$91.54 |
$2,315,578 |
D/D |
(25,000) |
648,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-10-08 |
4 |
AS |
$100.00 |
$2,223,800 |
D/D |
(22,238) |
648,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-10-08 |
4 |
OE |
$14.43 |
$320,894 |
D/D |
22,238 |
670,245 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-10-09 |
4 |
OE |
$14.43 |
$39,856 |
D/D |
2,762 |
650,769 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-10-09 |
4 |
AS |
$100.00 |
$276,200 |
D/D |
(2,762) |
648,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-11-30 |
4 |
OE |
$14.00 |
$1,421,500 |
D/D |
100,000 |
698,007 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2020-11-30 |
4 |
AS |
$125.00 |
$12,500,000 |
D/D |
(100,000) |
648,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2021-06-21 |
4 |
AS |
$125.58 |
$3,215,458 |
D/D |
(25,000) |
623,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2021-06-28 |
4 |
AS |
$156.55 |
$3,913,750 |
D/D |
(25,000) |
598,007 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
President |
• • – |
2021-06-30 |
4 |
AS |
$165.00 |
$4,125,000 |
D/D |
(25,000) |
573,007 |
0 |
% |
|
67 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
